GlassScriptPhysician profile
Maria D Nieto
NPI 1871729665
$10,602.07
in general payments reported to CMS, 2019-2025
31 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,725 · 2020: $959 · 2021: $2,199 · 2022: $739 · 2023: $2,045 · 2024: $343 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,131 · Travel and Lodging: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,130.57 |
| Travel and Lodging | $848.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $3,151.36 | 2019-2023 | Altis |
| Medtronic, INC. | $2,544.88 | 2021-2025 | Interstim |
| Axonics, INC. | $2,317.15 | 2020-2022 | |
| Medtronic USA, INC. | $335.62 | 2019-2020 | |
| Therapeuticsmd, INC. | $292.27 | 2019-2020 | |
| Abbvie INC. | $290.42 | 2019-2022 | |
| Intuitive Surgical, INC. | $171.26 | 2019-2020 | |
| Duchesnay USA Incorporated | $171.09 | 2019 | |
| Pfizer INC. | $159.17 | 2019-2022 | |
| Medtronic Vascular, INC. | $125.00 | 2019 | |
| Myovant Sciences INC. | $123.03 | 2022 | |
| Medical Device Business Services, INC. | $122.08 | 2019 | |
| Allergan, INC. | $112.61 | 2019-2021 | |
| Caldera Medical, INC | $96.15 | 2022-2025 | |
| Boston Scientific Corporation | $89.47 | 2025 | Axonics |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $73.32 | 2022 | |
| Organogenesis INC. | $68.77 | 2023 | Puraply |
| Valencia Technologies Corporation | $53.97 | 2025 | Ecoin Device Kit |
| Heron Therapeutics, INC. | $45.94 | 2022-2023 | Aponvie |
| Laborie Medical Technologies Corp. | $34.76 | 2024-2025 | Aquarius Lt, Urgent PC Neuromodulation System |
| Becton, Dickinson and Company | $32.92 | 2023 | Bd Onclarity |
| Mayne Pharma Commercial LLC | $31.23 | 2022 | |
| Hologic Sales and Service, LLC | $26.81 | 2025 | Novasure, Myosure Tissue Removal Device |
| Ethicon US, LLC | $23.26 | 2019 | |
| Millicent US INC | $19.84 | 2019 | |
| Urovant Sciences INC | $18.75 | 2022 | |
| Viiv Healthcare Company | $15.93 | 2024 | Rukobia |
| Currax Pharmaceuticals LLC | $15.20 | 2022 | |
| Mylan Pharmaceuticals INC. | $14.46 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.19 | 2019 | |
| Merck Sharp & Dohme LLC | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Nieto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.